Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies
about
Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis)Host immunity to Cryptococcus neoformansCD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice.Salivary Immunoglobulin Gene Expression in Patients with Caries.Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life.Elevated Membrane and Soluble CD64: A Novel Marker Reflecting Altered FcγR Function and Disease in Early Rheumatoid Arthritis That Can Be Regulated by Anti-Rheumatic Treatment.Characterization of NF-κB Reporter U937 Cells and Their Application for the Detection of Inflammatory Immune-Complexes.An FcγRIIa polymorphism with decreased C-reactive protein binding is associated with sepsis and decreased monocyte HLA-DR expression in trauma patientsFCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission.Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions.CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP.Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial.Mouse and human FcR effector functions.Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation.Charge heterogeneity: Basic antibody charge variants with increased binding to Fc receptors.Phagocytosis Enhances Lysosomal and Bactericidal Properties by Activating the Transcription Factor TFEB.Selection of IgG Variants with Increased FcRn Binding Using Random and Directed Mutagenesis: Impact on Effector Functions.The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.NK Cells and γδT Cells for Relapse Protection After Allogeneic Hematopoietic Cell Transplantation (HCT).Autoantibodies against the Immunoglobulin-Binding Region of Ro52 Link its Autoantigenicity with Pathogen Neutralization.Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors.Detection of antidrug antibodies against human therapeutic antibodies lacking Fc-effector functions by usage of soluble Fcγ receptor I.Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy.The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions.Autoantibodies in SLE: Specificities, Isotypes and Receptors
P2860
Q26801165-B2A7CCB4-1330-4698-829F-5152A92237F1Q26823438-87C1143F-A0D0-48DC-83AB-281A03FC39A2Q33426121-E1CB8FBB-5181-442A-8315-6AFB6D6C549BQ33646143-84A07D4A-4BEC-41BD-98B0-830A7AF4941BQ35569901-2629DAFB-5699-4098-AE8C-2F0A1BD82C31Q35788046-A9162A38-25EA-444C-AF7D-5CFE057A3023Q36032375-2DDBB7E1-6AC6-4FB4-A6FA-6B87739CB8C6Q36210491-DC60941D-9FC7-4C25-9C70-F6DFA941F68CQ36302010-67A02348-4842-4587-B0B2-117D3DD1BD4CQ36994530-0CD7018B-E06F-4DD8-842C-43BC1E9BC251Q37007977-904BE289-6831-4733-A634-09E652697DD3Q37415233-CDE7E330-BA3B-4718-88B6-A7464B61F90EQ38385131-0FAA1E8D-638A-4DB9-9CE7-98A4FB0F1704Q38615349-76FBE64C-F60C-464F-9EC3-649A0844BD6BQ38635500-CD121357-788D-484A-821E-F0E2A2E3A2CDQ38728589-1A490F68-85EA-4AA4-AFC4-984DEC563EF1Q39454978-BEBA8ED8-28DB-485B-B6E9-FDB51826C593Q40619068-FBBDDB28-C1CC-46A7-8CC1-0C5D646DE758Q42173120-402E3C5C-B643-4F37-BC49-A90F21F1B45DQ42315522-AC94477D-D39D-4439-B5FC-3D1F2EEFAFCBQ49333274-050E88F6-4653-41A6-82AD-7A37188F64C6Q49789469-C310BDE7-F27A-43A0-AD78-BD61B7794C66Q51321746-FA0BE76D-D65E-4FD9-81B1-81D9384DB1E2Q51539516-A66F81BA-77AD-4940-8B80-BE9FEF3A647AQ52571242-281B5917-23A2-4521-A38D-772AD09D0C1DQ55417775-A7C94103-576D-4CAA-A26A-C134DE08181BQ56806670-5BD2E1FE-58B6-46D1-AB89-2F7B4C19930E
P2860
Contribution of Human FcγRs to Disease with Evidence from Human Polymorphisms and Transgenic Animal Studies
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Contribution of Human FcγRs to ...... and Transgenic Animal Studies
@ast
Contribution of Human FcγRs to ...... and Transgenic Animal Studies
@en
type
label
Contribution of Human FcγRs to ...... and Transgenic Animal Studies
@ast
Contribution of Human FcγRs to ...... and Transgenic Animal Studies
@en
prefLabel
Contribution of Human FcγRs to ...... and Transgenic Animal Studies
@ast
Contribution of Human FcγRs to ...... and Transgenic Animal Studies
@en
P2860
P356
P1476
Contribution of Human FcγRs to ...... and Transgenic Animal Studies
@en
P2093
Aurélie Gouel-Chéron
Friederike Jönsson
P2860
P356
10.3389/FIMMU.2014.00254
P577
2014-05-30T00:00:00Z